Betamethasone 17-valerate: a new alcoholic formulation for psoriasis of the scalp.

Betamethasone 17-valerate: a new alcoholic formulation for psoriasis of the scalp.

Comparison of betamethasone valerate solution with phototherapy (UVB comb) in scalp psoriasis treatment.

Patients and treatment The study comprised 44 adult patients with scalp psoriasis. Patients using oral as well as topical medications known to a¡ect psoriasis were excluded. Furthermore, patients receiving local treatment known to a¡ect psoriasis within 2 weeks and taking oral medications within 4 weeks of the study commencing were excluded. Although the patients were randomly allocated a group...

Betamethasone 17-valerate by aerosol in childhood asthma

Frears, J. F., Wilson, L. C., and Friedman, M. (1973). Archives of Disease in Childhood, 48, 856. Betamethasone 17-valerate by aerosol in childhood asthma. A double-blind cross-over trial of betamethasone 17-valerate (B17V) administered by aerosol was carried out by alternating two placebo periods with two treated periods at monthly intervals in 20 children with severe asthma. During the trial,...

Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.

A new compound product containing calcipotriol 50 nanograms per gm and betamethasone dipropionate 0.5mg per gm (Dovobet, LEO Pharma) in an ointment base was recently introduced in Canada for the treatment of psoriasis. Known as Daivobet in Europe, it was introduced to the Danish Market in 2001, and approved for marketing by the European Union. This compound has been shown to be more active than...

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis

BACKGROUND Fixed combination calcipotriol as hydrate (Cal) 50 µg/g plus betamethasone as dipropionate (BD) 0.5 mg/g aerosol foam is an alcohol-free treatment for psoriasis. Betamethasone 17-valerate 2.25 mg (BV)-medicated plasters are recommended for treating psoriasis plaques localized in difficult-to-treat (DTT; elbow, knee, anterior face of the tibia) areas. OBJECTIVE The aim of this study...